Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sredni

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Immunology|August 1, 1990
Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatinB Sredni, Y Kalechman, M Albeck, et al.
Cancer|October 15, 1993
Vitiligo autoantibodies are effective against melanomaP Fishman, E Azizi, Y Shoenfeld, et al.
Annals of the New York Academy of Sciences|March 23, 2004
Tellurium compound AS101 induces PC12 differentiation and rescues the neurons from apoptotic deathD Makarovsky, Y Kalechman, T Sonino, et al.
Cancer Research|March 1, 1991
Protective and restorative role of AS101 in combination with chemotherapyY Kalechman, M Albeck, M Oron, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1988
The biological activity and immunotherapeutic properties of AS-101, a synthetic organotellurium compoundB Sredni, R R Caspi, S Lustig, et al.
Advances in Pharmacological Sciences|December 15, 2010
Monoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression-An Animal Model StudyO Malkesman, T Asaf, L Shbiro, et al.
Cellular Immunology|June 17, 1998
The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB/c miceH Rosenblatt-Bin, Y Kalechman, A Vonsover, et al.
Oncogene|September 3, 2008
Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancerI Wolf, S Levanon-Cohen, S Bose, et al.
International Journal of Cancer|January 3, 1996
The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal modelsB Sredni, R H Xu, M Albeck, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Immunology|August 1, 1990
Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatinB Sredni, Y Kalechman, M Albeck, et al.
Cancer|October 15, 1993
Vitiligo autoantibodies are effective against melanomaP Fishman, E Azizi, Y Shoenfeld, et al.
Annals of the New York Academy of Sciences|March 23, 2004
Tellurium compound AS101 induces PC12 differentiation and rescues the neurons from apoptotic deathD Makarovsky, Y Kalechman, T Sonino, et al.
Cancer Research|March 1, 1991
Protective and restorative role of AS101 in combination with chemotherapyY Kalechman, M Albeck, M Oron, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1988
The biological activity and immunotherapeutic properties of AS-101, a synthetic organotellurium compoundB Sredni, R R Caspi, S Lustig, et al.
Advances in Pharmacological Sciences|December 15, 2010
Monoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression-An Animal Model StudyO Malkesman, T Asaf, L Shbiro, et al.
Cellular Immunology|June 17, 1998
The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB/c miceH Rosenblatt-Bin, Y Kalechman, A Vonsover, et al.
Oncogene|September 3, 2008
Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancerI Wolf, S Levanon-Cohen, S Bose, et al.
International Journal of Cancer|January 3, 1996
The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal modelsB Sredni, R H Xu, M Albeck, et al.
Pageof 10